The Valley Desk

ReviewCurrent pharmaceutical biotechnologyPublished

Pharmacogenomic-based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety Disorders

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Jefferson Health. Affiliation source

Institution
Jefferson Health

Publication record

Type
Review
Venue
Current pharmaceutical biotechnology
Published
Subject terms
Humans; Genetic Predisposition to Disease; Facial Expression; Emotions; Anxiety Disorders; Schizophrenia; Pharmacogenetics; Epigenesis, Genetic; Genome-Wide Association Study; Pharmacogenomics; ADHD; Autism
PubMed ID
41830575
PubMed Central ID
PMC13698029
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal